Skip to content
Trial Eligibility
Menu

Natural History of Bronchiectasis

NCT00943514

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Background: Bronchiectasis is a disease characterized by airways that are inflamed, abnormally dilated, and chronically infected. Individuals with bronchiectasis have a history of chronic and recurring respiratory infections. Depending on the underlying cause, these infections may involve the entire respiratory tract, resulting in sinus, ear, and lung disease. Bronchiectasis continues to be a significant problem in developing countries and in specific groups of individuals, particularly in people who have cystic fibrosis.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Bronchiectasis
  • Cystic Fibrosis
  • Autoimmune Disease
  • Common Variable Immunodeficiency

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
5 to 100 years
Sex
All
Healthy volunteers
Accepted
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Last updated on ClinicalTrials.gov
October 2, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • National Institutes of Health Clinical Center · Bethesda, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.